The Oncosearch | Oncotarget

P2Y₂R activation by nucleotides released from the highly metastatic breast cancer cell contributes to pre-metastatic niche formation by mediating lysyl oxidase secretion, collagen crosslinking, and monocyte recruitment Research Paper

Young Nak Joo, Hana Jin, So Young Eun, Sang Won Park, Ki Churl Chang, Hye Jung Kim

Published Sep 2, 2014 · Vol. 5, No. 19 · pp. 9322-9334

Co-expression of MET and CD47 is a novel prognosticator for survival of luminal-type breast cancer patients Clinical Research Papers

IrÃ¨ne Baccelli, Albrecht Stenzinger, Vanessa Vogel, Berit Maria Pfitzner, Corinna Klein, Markus Wallwiener, Martina Scharpff, Massimo Saini, Tim Holland-Letz, Hans-Peter Sinn, Andreas Schneeweiss, Carsten Denkert, Wilko Weichert, Andreas Trumpp

Published Sep 2, 2014 · Vol. 5, No. 18 · pp. 8147-8160

Combining targeted drugs to overcome and prevent resistance of solid cancers with some stem-like cell features Research Paper

Elina Jokinen, Niina Laurila, Peppi Koivunen, Jussi P. Koivunen

Published Sep 2, 2014 · Vol. 5, No. 19 · pp. 9295-9307

Prolactin induces up-regulation of its cognate receptor in breast cancer cells via transcriptional activation of its generic promoter by cross-talk between ERÎ± and STAT5 Research Paper

Raghuveer Kavarthapu, Chon-Hwa Tsai Morris, Maria L. Dufau

Published Aug 21, 2014 · Vol. 5, No. 19 · pp. 9079-9091

A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumors Clinical Research Papers

Hatem H. Soliman, Erica Jackson, Tony Neuger, Claire E. Dees, Donald R. Harvey, Hyo Han, Roohi Ismail-Khan, Susan Minton, Nicholas N. Vahanian, Charles Link, Daniel M. Sullivan, Scott Antonia

Published Aug 21, 2014 · Vol. 5, No. 18 · pp. 8136-8146

Keywords: Indoximod, 1-methyl-D-tryptophan, immunomodulator, docetaxel, indoleamine 2, 3 dioxygenase

MicroRNA-339-5p inhibits colorectal tumorigenesis through regulation of the MDM2/p53 signaling Research Paper

Cen Zhang, Juan Liu, Xiaolong Wang, Rui Wu, Meihua Lin, Saurabh V. Laddha, Qifeng Yang, Chang S. Chan, Zhaohui Feng

Published Aug 21, 2014 · Vol. 5, No. 19 · pp. 9106-9117

Acetylation-defective mutants of PparÎ³ are associated with decreased lipid synthesis in breast cancer cells Priority Research Paper

Lifeng Tian, Chenguang Wang, Fred K. Hagen, Michael Gormley, Sankar Addya, Raymond Soccio, Mathew C. Casimiro, Jie Zhou, Michael J. Powell, Ping Xu, Haiteng Deng, Anthon A. Sauve, Richard G. Pestell

Published Aug 19, 2014 · Vol. 5, No. 17 · pp. 7303-7315

Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease Research Paper

Heidi N. Hilton, Tram B. Doan, J. Dinny Graham, Samantha R. Oakes, Audrey Silvestri, Nicole Santucci, Silke Kantimm, Lily I. Huschtscha, Christopher J. Ormandy, John W. Funder, Evan R. Simpson, Elizabeth S. Kuczek, Peter J. Leedman, Wayne D. Tilley, Peter J. Fuller, George E. O. Muscat, Christine L. Clarke

Published Aug 16, 2014 · Vol. 5, No. 18 · pp. 8651-8664

Diacylglycerol kinase Î± promotes 3D cancer cell growth and limits drug sensitivity through functional interaction with Src Research Paper

Pedro Torres-Ayuso, Manuel Daza-MartÃn, Jorge MartÃn-PÃ©rez, Antonia Ãvila-Flores, Isabel MÃ©rida

Published Aug 12, 2014 · Vol. 5, No. 20 · pp. 9710-9726

Loss of the obscurin-RhoGEF downregulates RhoA signaling and increases microtentacle formation and attachment of breast epithelial cells Research Paper

Nicole A. Perry, Michele I. Vitolo, Stuart S. Martin, Aikaterini Kontrogianni-Konstantopoulos

Published Aug 10, 2014 · Vol. 5, No. 18 · pp. 8558-8568

Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors Research Paper

Burhan Hassan, Argun Akcakanat, Takafumi Sangai, Kurt W. Evans, Farrell Adkins, Agda Karina Eterovic, Hao Zhao, Ken Chen, Huiqin Chen, Kim-Anh Do, Shelly M. Xie, Ashley M. Holder, Aung Naing, Gordon B. Mills, Funda Meric-Bernstam

Published Aug 10, 2014 · Vol. 5, No. 18 · pp. 8544-8557

Co-ordination of cell cycle, migration and stem cell-like activity in breast cancer Research Paper

Rebecca Lamb, Michael P. Lisanti, Robert B. Clarke, GÃ¶ran Landberg

Published Aug 4, 2014 · Vol. 5, No. 17 · pp. 7833-7842

A generic cycling hypoxia-derived prognostic gene signature: application to breast cancer profiling Research Paper

Romain Boidot, Samuel Branders, Thibault Helleputte, Laila Illan Rubio, Pierre Dupont, Olivier Feron

Published Jul 31, 2014 · Vol. 5, No. 16 · pp. 6947-6963

A central role for TRPS1 in the control of cell cycle and cancer development Research Paper

Lele Wu, Yuzhi Wang, Yan Liu, Shiyi Yu, Hao Xie, Xingjuan Shi, Sheng Qin, Fei Ma, Tuan Zea Tan, Jean Paul Thiery, Liming Chen

Published Jul 31, 2014 · Vol. 5, No. 17 · pp. 7677-7690

Estrogen Receptor Alpha Prevents Bladder Cancer Development via INPP4B inhibited Akt Pathway in vitro and in vivo Research Paper

Iawen Hsu, Chiuan-Ren Yeh, Spencer Slavin, Hiroshi Miyamoto, George Netto, Yu-Chieh Tsai, Mesut Muyan, Xue-Ru Wu, Shuyuan Yeh

Published Jul 29, 2014 · Vol. 5, No. 17 · pp. 7917-7935

Keywords: bladder cancer, estrogen receptor alpha, BBN, INPP4B

The BCL9-2 proto-oncogene governs estrogen receptor alpha expression in breast tumorigenesis Research Paper

Nathalie Zatula, Maria Wiese, Jens Bunzendahl, Walter Birchmeier, Christina Perske, Annalen Bleckmann, Felix H. Brembeck

Published Jul 25, 2014 · Vol. 5, No. 16 · pp. 6770-6787

Oncogene-triggered suppression of DNA repair leads to DNA instability in cancer Research Paper

Julia A. Yaglom, Christopher McFarland, Leonid Mirny, Michael Y. Sherman

Published Jul 25, 2014 · Vol. 5, No. 18 · pp. 8367-8378

Release of Ca²⁺ from the endoplasmic reticulum and its subsequent influx into mitochondria trigger celastrol-induced paraptosis in cancer cells Research Paper

Mi Jin Yoon, A Reum Lee, Soo Ah Jeong, You-Sun Kim, Jin Yeop Kim, Yong-Jun Kwon, Kyeong Sook Choi

Published Jul 25, 2014 · Vol. 5, No. 16 · pp. 6816-6831

Therapeutic CK2 inhibition attenuates diverse prosurvival signaling cascades and decreases cell viability in human breast cancer cells Research Paper

G. Kenneth Gray, Braden C. McFarland, Amber L. Rowse, Sara A. Gibson, Etty N. Benveniste

Published Jul 23, 2014 · Vol. 5, No. 15 · pp. 6484-6496

RASAL2 down-regulation in ovarian cancer promotes epithelial-mesenchymal transition and metastasis Research Paper

Yuting Huang, Meng Zhao, Haixu Xu, Ke Wang, Zheng Fu, Yuan Jiang, Zhi Yao

Published Jul 23, 2014 · Vol. 5, No. 16 · pp. 6734-6745

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

P2Y₂R activation by nucleotides released from the highly metastatic breast cancer cell contributes to pre-metastatic niche formation by mediating lysyl oxidase secretion, collagen crosslinking, and monocyte recruitment Research Paper

Co-expression of MET and CD47 is a novel prognosticator for survival of luminal-type breast cancer patients Clinical Research Papers

Combining targeted drugs to overcome and prevent resistance of solid cancers with some stem-like cell features Research Paper

Prolactin induces up-regulation of its cognate receptor in breast cancer cells via transcriptional activation of its generic promoter by cross-talk between ERÎ± and STAT5 Research Paper

A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumors Clinical Research Papers

MicroRNA-339-5p inhibits colorectal tumorigenesis through regulation of the MDM2/p53 signaling Research Paper

Acetylation-defective mutants of PparÎ³ are associated with decreased lipid synthesis in breast cancer cells Priority Research Paper

Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease Research Paper

Diacylglycerol kinase Î± promotes 3D cancer cell growth and limits drug sensitivity through functional interaction with Src Research Paper

Loss of the obscurin-RhoGEF downregulates RhoA signaling and increases microtentacle formation and attachment of breast epithelial cells Research Paper

Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors Research Paper

Co-ordination of cell cycle, migration and stem cell-like activity in breast cancer Research Paper

A generic cycling hypoxia-derived prognostic gene signature: application to breast cancer profiling Research Paper

A central role for TRPS1 in the control of cell cycle and cancer development Research Paper

Estrogen Receptor Alpha Prevents Bladder Cancer Development via INPP4B inhibited Akt Pathway in vitro and in vivo Research Paper

The BCL9-2 proto-oncogene governs estrogen receptor alpha expression in breast tumorigenesis Research Paper

Oncogene-triggered suppression of DNA repair leads to DNA instability in cancer Research Paper

Release of Ca²⁺ from the endoplasmic reticulum and its subsequent influx into mitochondria trigger celastrol-induced paraptosis in cancer cells Research Paper

Therapeutic CK2 inhibition attenuates diverse prosurvival signaling cascades and decreases cell viability in human breast cancer cells Research Paper

RASAL2 down-regulation in ovarian cancer promotes epithelial-mesenchymal transition and metastasis Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

P2Y2R activation by nucleotides released from the highly metastatic breast cancer cell contributes to pre-metastatic niche formation by mediating lysyl oxidase secretion, collagen crosslinking, and monocyte recruitment Research Paper

Co-expression of MET and CD47 is a novel prognosticator for survival of luminal-type breast cancer patients Clinical Research Papers

Combining targeted drugs to overcome and prevent resistance of solid cancers with some stem-like cell features Research Paper

Prolactin induces up-regulation of its cognate receptor in breast cancer cells via transcriptional activation of its generic promoter by cross-talk between ERÎ± and STAT5 Research Paper

A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumors Clinical Research Papers

MicroRNA-339-5p inhibits colorectal tumorigenesis through regulation of the MDM2/p53 signaling Research Paper

Acetylation-defective mutants of PparÎ³ are associated with decreased lipid synthesis in breast cancer cells Priority Research Paper

Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease Research Paper

Diacylglycerol kinase Î± promotes 3D cancer cell growth and limits drug sensitivity through functional interaction with Src Research Paper

Loss of the obscurin-RhoGEF downregulates RhoA signaling and increases microtentacle formation and attachment of breast epithelial cells Research Paper

Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors Research Paper

Co-ordination of cell cycle, migration and stem cell-like activity in breast cancer Research Paper

A generic cycling hypoxia-derived prognostic gene signature: application to breast cancer profiling Research Paper

A central role for TRPS1 in the control of cell cycle and cancer development Research Paper

Estrogen Receptor Alpha Prevents Bladder Cancer Development via INPP4B inhibited Akt Pathway in vitro and in vivo Research Paper

The BCL9-2 proto-oncogene governs estrogen receptor alpha expression in breast tumorigenesis Research Paper

Oncogene-triggered suppression of DNA repair leads to DNA instability in cancer Research Paper

Release of Ca2+ from the endoplasmic reticulum and its subsequent influx into mitochondria trigger celastrol-induced paraptosis in cancer cells Research Paper

Therapeutic CK2 inhibition attenuates diverse prosurvival signaling cascades and decreases cell viability in human breast cancer cells Research Paper

RASAL2 down-regulation in ovarian cancer promotes epithelial-mesenchymal transition and metastasis Research Paper

P2Y₂R activation by nucleotides released from the highly metastatic breast cancer cell contributes to pre-metastatic niche formation by mediating lysyl oxidase secretion, collagen crosslinking, and monocyte recruitment Research Paper

Release of Ca²⁺ from the endoplasmic reticulum and its subsequent influx into mitochondria trigger celastrol-induced paraptosis in cancer cells Research Paper